ELF4
protein-codingE74 like ETS transcription factor 4, the group of ETS transcription factor family
Gene summary
The protein encoded by this gene is a transcriptional activator that binds and activates the promoters of the CSF2, IL3, IL8, and PRF1 genes. The encoded protein is involved in natural killer cell development and function, innate immunity, and induction of cell cycle arrest in naive CD8+ cells. Two transcript variants encoding the same protein have been found for this gene.[provided by RefSeq, Jan 2010]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~46.8 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: XL
Disease ID:MONDO:0024770
Submitter: ClinGen
*ELF4* was first reported in relation to X-linked inheritance autoinflammatory syndrome, familial Behcet-like 2 in 2021 (Tyler et al., PMID: 34326534). X-linked familial Behcet-like autoinflammatory syndrome-2 is an X-linked recessive disorder characterized by inflammatory symptoms present in males within the first decade of life. Affected males most often present with oral mucosal ulceration and skin inflammation. Other variable features include gastrointestinal ulceration, arthritis, recurrent fevers, and iron deficiency anemia. ELF-4 deficiency is also known as X-linked deficiency in *ELF4* (DEX). It is characterized by mucosal inflammation and features resembling inflammatory bowel disease (IBD), in addition to the Behcet’s phenotype. *ELF4* is a transcription factor that regulates immune responses in macrophages. The loss of *ELF4* leads to hyperinflammatory response in macrophages, specifically with regard to IL-17 and TREM-1 signaling, which contributes to the phenotype. TREM-1 blockade has been shown to mitigate inflammation and intestinal pathology in ELF-4-deficient mouse models. More recently it has been shown that *ELF4* also regulates the inflammatory potential of CD4+ T cells (Bender et al, The Journal of Immunology, May 2024, https://doi.org/10.4049/jimmunol.212.supp.1259.5567). The clinical phenotype of ELF-4 deficiency includes fevers, oral and GI ulcers, abdominal pain, diarrhea, and arthritis. DEX is primarily observed in males though skewed X-chromosome inactivation and disease has been reported in females (Zhao R et al, PMID: 39976696). Seven variants (missense, nonsense, frameshift) that have been reported in nine probands in four publications (PMIDs: 34326534, 35266071, 38231408, 36823308) are included in this curation. More evidence is available in the literature, but the maximum score for genetic evidence (12 pts.) has been reached. The mechanism of pathogenicity appears to be loss of function. This gene-disease relationship is also supported by experimental evidence (e.g. animal models, expression studies) (PMIDs: 35266071, 34326534). Mouse studies including both knock-in (W250S mice; equivalent to the human W251S) and knock-out (Elf4 KO) mice showed that there was reduced perforin expression in cytotoxic T lymphocytes. Both the Elf4 KO and W250S mice indicate that the patient-derived *ELF4* variants are loss-of-function. Further, mice harboring the W230R missense variant (equivalent to the human W231R) showed significantly decreased viral clearance compared to those from WT mice. Bone marrow-derived macrophage (BMDM) from mutant mice showed similar impairment suggesting impaired ability for viral clearance. In summary, there is definitive evidence supporting the relationship between *ELF4* and X-linked inheritance autoinflammatory syndrome, familial Behcet-like 2. This has been repeatedly demonstrated in both the research and clinical diagnostic settings, and has been upheld over time This classification was approved by the ClinGen PIRD GCEP on the meeting date Jne 9, 2025 (SOP Version 10.1).
Inheritance Pattern: XL
Disease ID:MONDO:0024770
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: XL
Disease ID:MONDO:0018967
Submitter: Orphanet
Clinical Genomic Database (CGD)
Manifestation: Allergy/Immunology/Infectious
Intervention: Allergy/Immunology/Infectious
Rationale: The condition involves autoinflammatory manifestations, and medical management (eg, with steroids, TNFA blockade) have been described as beneficial; The condition may involve frequent infections, and prophylactic measures and prompt and aggressive management of infections may be beneficial
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to ELF4 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_001421.4. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 12 | 9 | 2 | 23 | ||
| missense | 2 | 106 | 10 | 1 | 119 | |
| nonsense | 2 | 1 | 11 | 14 | ||
| start loss | 0 | |||||
| frameshift | 2 | 1 | 3 | |||
| splice donor/acceptor (+/-2bp) | 12 | 12 | ||||
| Total | 6 | 2 | 141 | 19 | 3 | 171 |
Highest pathogenic variant AF is 0.0000027322876
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_001412.1 | 8 | MANE Select | |
| Ensembl | ENSP00000311280.6 | 8 | MANE Select | |
| RefSeq | NP_001120669.1 | 8 | Standard | |
| RefSeq | NP_001427694.1 | 8 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- TYROBP Causal Network
Biological Process
- natural killer cell proliferation
- NK T cell proliferation
- regulation of transcription by RNA polymerase II
- cell differentiation
- innate immune response
Molecular Function
- RNA polymerase II proximal promoter sequence-specific DNA binding
- DNA-binding transcription factor activity, RNA polymerase II-specific
- DNA-binding transcription activator activity, RNA polymerase II-specific
- protein binding
Cellular Component
- nucleus
- nucleoplasm
- nuclear body
- PML body
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000308167
- Coding exons
- 8
- Length
- 45843
- Individuals with no LoFs
- 125740
- Homozygous LoFs
- 1
- Heterozygous LoFs
- 6
- Defined
- 125747
- p
- 0.0000278
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 1.17 | 212 | 265 | 0.799 | 0.0000206 | 4274 |
| Missense (PolyPhen) | 55 | 92.085 | 0.59727 | 1625 | ||
| Synonymous | 0.629 | 111 | 120 | 0.927 | 0.0000104 | 1457 |
| Loss of Function | 2.60 | 5 | 16.3 | 0.306 | 0.00000126 | 264 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.000076 | 0.000062 | rare |
| Latino/Admixed American | 0.000036 | 0.000029 | rare |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0 | 0.0 | absent |
| Finnish | 0 | 0.0 | absent |
| European (Non-Finnish) | 0.000062 | 0.000044 | rare |
| South Asian | 0 | 0.0 | absent |
| Other | 0 | 0.0 | absent |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Transcriptional activator that binds to DNA sequences containing the consensus 5'-WGGA-3'. Transactivates promoters of the hematopoietic growth factor genes CSF2, IL3, IL8, and of the bovine lysozyme gene. Acts synergistically with RUNX1 to transactivate the IL3 promoter (By similarity). Also transactivates the PRF1 promoter in natural killer (NK) cells. Plays a role in the development and function of NK and NK T-cells and in innate immunity. Controls the proliferation and homing of CD8+ T-cells via the Kruppel-like factors KLF4 and KLF2 (By similarity). Controls cell senescence in a p53-dependent manner. Can also promote cellular transformation through inhibition of the p16 pathway. {ECO:0000250, ECO:0000269|PubMed:10207087, ECO:0000269|PubMed:14625302, ECO:0000269|PubMed:14976184, ECO:0000269|PubMed:19380490, ECO:0000269|PubMed:8895518, ECO:0000269|PubMed:9524226}.;
- Disease
- DISEASE: Note=A chromosomal aberration involving ELF4 has been found in a case of acute myeloid leukemia (AML). Translocation t(X;21)(q25-26;q22) with ERG. {ECO:0000269|PubMed:16303180}.;
Recessive Scores
- pRec
- 0.0870
Intolerance Scores
- LoFtool
- 0.359
- RVIS EVS
- -0.11
- RVIS percentile EVS
- 45.26
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- E
- Indispensability score
- 0.632
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |